Analyst Ratings for Solid Biosciences (SLDB)
SLDB Rating Summary
SLDB Price Target Summary
- Highest: $26.00 (Cantor Fitzgerald)
- Lowest: $9.00 (Barclays)
- Average: $17.82
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.82 (+80.3%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$17.82 (+80.3%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | Truist Securities | Danielle Bril | New Coverage | Buy (N/A) |
20.00 (N/A) |
9.10 (9.88) |
8.57% | Details |
| 3/20/2026 | Guggenheim | Debjit Chattopadhyay | New Coverage | Buy (N/A) |
26.00 (N/A) |
7.12 (9.88) |
38.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
